A rare case of pediatric neurogenic stunned myocardium (NSM) associated with a brain tumor is reported. A previously healthy 6-year-old boy presented with coma, and imaging studies revealed a brain tumor. On hospitalization day 3, he developed NSM and neurogenic pulmonary edema necessitating intensive cardiopulmonary support. Although blood marker levels of cardiac injury were elevated, his plasma and urinary norepinephrine levels were within normal limits. His cardiorespiratory functions markedly improved by hospitalization day 8. This case report may be one of the first to document plasma and urinary catecholamine levels in pediatric NSM. While solid conclusion cannot be drawn based on experience from a single case, these results suggest that pediatric NSM may not be catecholamine-induced.
INTRODUCTION
Neurogenic stunned myocardium (NSM) is an acquired, transient type of systolic dysfunction causally associated with a central nervous system (CNS) pathology. [1] Highly elevated plasma and CNS catecholamine levels following overactivation of the sympathetic nervous system are widely considered to be responsible for NSM. [1] Most NSM patients are elderly women, and NSM has been considered rare in pediatric individuals. [2] [3] [4] [5] [6] [7] [8] [9] We herein report a case of pediatric NSM associated with a brain tumor. Measurement of plasma and urinary catecholamine levels provides an insight into etiopathology of pediatric NSM.
CASE REPORT
A previously healthy 6-year-old boy presented to our emergency department with a rapidly progressive altered mental status. He was comatose and moderate right-sided hemiparesis was noted. Brain computed tomography together with brain magnetic resonance imaging revealed a hemorrhagic lesion extending from the thalamus to the midbrain with marked ventricular dilation. Bleeding from a preexisting brain tumor and subsequent hydrocephalus were suspected, and an emergency ventriculostomy was performed shortly after admission. Despite the improvement in his consciousness level after surgery, he became hypotensive, tachycardic and hypoxic on hospitalization day 3. A chest X-ray showed sharply defined pulmonary markings accompanied by blurring of the perivascular outlines, suggesting neurogenic pulmonary edema [ Figure 1a ]. Subsequent transthoracic echocardiography (TTE) showed left ventricular wall motion abnormalities with a markedly hypokinetic apex and a hyperkinetic base, that were compatible with NSM [ Figure 1b systolic function, and PaO 2 /FiO 2 ratio were summarized in Figure 2 . The left ventricular ejection fraction (LVEF) on TTE was 35%, and the PaO 2 /FiO 2 ratio was 275. He received intensive cardiopulmonary support with the administration of inotropic agents and positive endexpiratory pressure. At onset, blood marker levels were as follows: White blood cell count, 14100/mm 3 ; N-terminal pro-brain natriuretic peptide, 2800 pg/mL; epinephrine, 140 pg/mL; norepinephrine, 309 pg/mL; dopamine, 17 pg/mL; aldosterone, 212 pg/mL; and blood glucose, 141 mg/dL [ Table 1 ]. Urinary epinephrine and norepinephrine levels were 35 pg/mL and 91 pg/mL, respectively [ Table 1 ]. Supportive therapy substantially improved his cardiorespiratory functions by hospitalization day 8: A follow-up TTE exhibited normal-shaped cardiac ventricles. His LVEF increased to 55%, and the PaO 2 /FiO 2 ratio increased to 460 [ Figure 2 ]. On hospitalization day 11, he was able to undergo surgery to remove the tumor. Recovery from surgery was uneventful, and he was discharged home with mild deficits 2 months after admission. Permission was granted from the patient's guardians for this report.
DISCUSSION

NSM is most frequently associated with severe c e r e b r o v a s c u l a r d i s o r d e r s l i k e s u b a r a c h n o i d hemorrhage.
[1] Risk factors for NSM include advanced age and female gender, and elevated catecholamine (epinephrine/norepinephrine) levels in plasma and CNS are causally associated with NSM. [1] Norepinephrine rather than epinephrine seems to be more relevant in the pathogenesis of NSM. [1] It is not unusual in clinical practice for NSM patients to exhibit plasma and urinary catecholamine levels that are elevated 10-20 fold more compared with levels in normal healthy subjects. [1] NSM has only been rarely reported in the pediatric population. After a vigorous literature search, only 10 cases (including ours) of pediatric NSM were identified [ Table 2 ]. [2] [3] [4] [5] [6] [7] [8] This case report may be one of the first to document plasma and urinary catecholamine levels in pediatric NSM patients. The plasma and urinary norepinephrine levels were within normal range except mildly elevated urinary epinephrine levels [ Table 1 ], suggesting that pediatric NSM may not be catecholamineinduced. An interval more than 48 h between symptom onset and development of NSM may indicate that acutely elevated plasma catecholamine levels at onset might have returned to normal by the time of sample collection. However, urinary catecholamine levels might have been elevated as well if there had been such early elevation in plasma catecholamines: Normal urinary catecholamine levels may be another indirect evidence to support our hypothesis.
In pediatric NSM, causative brain lesions are mostly brainstem/cerebellar tumors and are frequently accompanied by hydrocephalus [ Table 2 ]. [2] [3] [4] [5] [6] [7] [8] This pattern indicates that compression to the vasomotor nuclei in the medulla oblongata may be a triggering event for NSM. Frequently concomitant neurogenic pulmonary edema [ Table 2 ] may also be explained by the overactivation of the medullary vasomotor nuclei. [11] NSM by itself may 
